<?xml version="1.0" encoding="UTF-8"?>
<p>The CCI was scored according to 19 preoperative comorbidities; the method was consistent with that of Charlson 
 <italic>et al</italic>.
 <xref rid="tca13519-bib-0012" ref-type="ref">
  <sup>12</sup>
 </xref> The GPS was defined as follows: score 0, albumin level ≥ 3.5 g/dL and CRP level &lt;0.5 mg/dL; score 1, albumin level &lt;3.5 g/dL or CRP level ≥ 0.5 mg/dL; score 2, albumin level &lt;3.5 g/dL and CRP ≥0.5 mg/dL. This scoring method was similar to that of McMillan 
 <italic>et al</italic>.
 <xref rid="tca13519-bib-0013" ref-type="ref">
  <sup>13</sup>
 </xref> Postoperative pulmonary complications were defined as follows: Pulmonary fistula, prolonged air leakage over seven postoperative days or the need for reoperation or pleurodesis; Postoperative pneumonia, new infiltration on chest roentgenogram (X‐P) or CT scan which needed antibiotic therapy; respiratory failure, management with a ventilator over two postoperative days, or the need for reintubation or tracheotomy. The overall survival time was calculated from the date of surgery to the time of death or the last follow‐up. The follow‐up was until 18 September 2019. This study was approved by the ethics committee of the Shanghai Public Health Clinical Center (Approval No. [2018] Y038).
</p>
